British firm Beckley Canopy Therapeutics raises millions for cannabinoid R&D.
Product labeling regulations in California still apply to cannabis companies and the costs of noncompliance are high.
In this piece, the application of gas chromatography with infrared detection (GC/IR) to characterizing organic compounds in cannabis products is discussed. The identification of specific isomers of similar organic compounds is critical to determining the quality of cannabis products.
Aphria has found itself in hot water and the target of multiple legal claims after a series of damning reports claimed the company was engaged in fraudulent practices.
Wayland Group (formerly Maricann) is establishing itself in Europe and beyond with a focus on cannatech.
Canadian recreational legalization in late October may come to be seen as the highlight of the cannabis year, but in Europe, the fourth quarter tops off quite an amazing 2018 too.
The country wants to put itself on the map as the recreational “icebreaker” of Europe per comments of a leading consumer rights group.
The cultivation bid has already been stalled in federal court once and Round II is shaping up to be just as fractious. Is there any end to the drama in sight?
Massachusetts gave the green light to dispensaries last week, opening up the first recreational cannabis market on the East Coast.
Patients can now get medical cannabis by prescription in the UK. But what does a Schedule II prescription issuance really mean? A few lessons from Germany and other places…
